NLRP3 and colitis: Compared with WT mice, deletion of NLRP3 significantly attenuated the severity of symptoms in DSS-induced colitis, with decreased weight loss, colon shortening and spleen enlargement (Figure 3B, Figure 3C and Figure 3D).